David C Klonoff

Summary

Publications

  1. doi SMBG out of control: the need for educating patients about control solution
    Tahir Chaudhry
    David C Klonoff, FACP, Diabetes Research Institute, Mills Peninsula Health Services, 100 South San Mateo Dr, Room 5147, San Mateo, CA 94401
    Diabetes Educ 39:689-95. 2013
  2. pmc Do currently available blood glucose monitors meet regulatory standards? 1-day public meeting in Arlington, Virginia
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, CA 94401, USA
    J Diabetes Sci Technol 7:1071-83. 2013
  3. pmc ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, CA 94401, USA
    J Diabetes Sci Technol 7:1005-10. 2013
  4. pmc The current status of mHealth for diabetes: will it be the next big thing?
    David C Klonoff
    Mills Peninsula Health Services, 100 S San Mateo Dr, San Mateo, CA 94401, USA
    J Diabetes Sci Technol 7:749-58. 2013
  5. pmc Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes
    David C Klonoff
    Diabetes Research Institute, Mills Peninsula Health Services, San Mateo, California 94401, USA
    J Diabetes Sci Technol 5:1529-48. 2011
  6. pmc Overview of fluorescence glucose sensing: a technology with a bright future
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, CA 94401, USA
    J Diabetes Sci Technol 6:1242-50. 2012
  7. pmc Progress in development of an artificial pancreas
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, California 94401, USA
    J Diabetes Sci Technol 3:1002-4. 2009
  8. pmc Insulin pump safety meeting: summary report
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, California, USA
    J Diabetes Sci Technol 3:396-402. 2009
  9. doi Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, California 94401, USA
    J Clin Endocrinol Metab 96:2968-79. 2011
  10. ncbi Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery
    David C Klonoff
    Mills Peninsula Diabetes Research Institute, San Mateo, California 94401, USA
    Pediatr Endocrinol Rev 1:94-100. 2003

Detail Information

Publications18

  1. doi SMBG out of control: the need for educating patients about control solution
    Tahir Chaudhry
    David C Klonoff, FACP, Diabetes Research Institute, Mills Peninsula Health Services, 100 South San Mateo Dr, Room 5147, San Mateo, CA 94401
    Diabetes Educ 39:689-95. 2013
    ..The purpose of this project was to determine how prevalent control solution calibration is in patients who perform self-monitoring of blood glucose (SMBG)...
  2. pmc Do currently available blood glucose monitors meet regulatory standards? 1-day public meeting in Arlington, Virginia
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, CA 94401, USA
    J Diabetes Sci Technol 7:1071-83. 2013
    ..approved BGMs perform according to International Organization for Standardization standards? (3) How do approved BGMs perform when used by patients and health care professionals? (4) What could be the consequence of poor BGM performance? ..
  3. pmc ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, CA 94401, USA
    J Diabetes Sci Technol 7:1005-10. 2013
    ....
  4. pmc The current status of mHealth for diabetes: will it be the next big thing?
    David C Klonoff
    Mills Peninsula Health Services, 100 S San Mateo Dr, San Mateo, CA 94401, USA
    J Diabetes Sci Technol 7:749-58. 2013
    ..mHealth for diabetes is making rapid strides and is expected to be a transforming technology that will be the next big thing...
  5. pmc Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes
    David C Klonoff
    Diabetes Research Institute, Mills Peninsula Health Services, San Mateo, California 94401, USA
    J Diabetes Sci Technol 5:1529-48. 2011
    ....
  6. pmc Overview of fluorescence glucose sensing: a technology with a bright future
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, CA 94401, USA
    J Diabetes Sci Technol 6:1242-50. 2012
    ..If currently vexing technical and engineering and biocompatibility problems can be overcome, then this approach could lead to a new family of continuous glucose monitors...
  7. pmc Progress in development of an artificial pancreas
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, California 94401, USA
    J Diabetes Sci Technol 3:1002-4. 2009
    ..The novel approaches described in these articles are expected to bring us much closer to realization of a commercially available closed loop system for controlling glucose levels in patients with diabetes...
  8. pmc Insulin pump safety meeting: summary report
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, California, USA
    J Diabetes Sci Technol 3:396-402. 2009
    ..There was consensus among meeting participants that insulin pump therapy is beneficial in patients of all ages and that insulin pump safety must be assured through careful regulation...
  9. doi Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, California 94401, USA
    J Clin Endocrinol Metab 96:2968-79. 2011
    ..The aim was to formulate practice guidelines for determining settings where patients are most likely to benefit from the use of continuous glucose monitoring (CGM)...
  10. ncbi Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery
    David C Klonoff
    Mills Peninsula Diabetes Research Institute, San Mateo, California 94401, USA
    Pediatr Endocrinol Rev 1:94-100. 2003
    ..new routes of insulin administration, including inhaled, oral, buccal, nasal, and transdermal drug delivery systems. These new technologies will facilitate proper treatment of type 1 diabetes and improve the lives of affected patients...
  11. pmc Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective
    David C Klonoff
    Diabetes Research Institute, Mills Peninsula Health Services, San Mateo, California, USA
    J Diabetes Sci Technol 5:755-67. 2011
    ..Greater doses of insulin, but with dosing based on more accurate glucose levels, might result in less hypoglycemia, less hyperglycemia, and less glycemic variability...
  12. pmc Innovations in technology for the treatment of diabetes: clinical development of the artificial pancreas (an autonomous system)
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, California, USA
    J Diabetes Sci Technol 5:804-26. 2011
    ..The patients discussed how clinical science, system components, and regulatory policies will all need to harmonize in order to achieve the goal of seeing an AP product brought forward to the marketplace for patients to use...
  13. doi Incretin therapy for type 2 diabetes mellitus
    David C Klonoff
    Diabetes Research Institute, Mills Peninsula Health Services, San Mateo, CA 94401, USA
    Adv Ther 27:881-94. 2010
    ..The incretinbased agents reduce hyperglycemia and provide beneficial effects on surrogate markers of cardiovascular risk, including weight gain, elevated blood pressure, and dyslipidemia...
  14. pmc The food and drug administration is now preparing to establish tighter performance requirements for blood glucose monitors
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, California 94401, USA
    J Diabetes Sci Technol 4:499-504. 2010
    ....
  15. ncbi Continuous glucose monitoring: roadmap for 21st century diabetes therapy
    David C Klonoff
    Mills Peninsula Health Services Diabetes Research Institute, 100 S San Mateo Dr, Rm 3124, San Mateo, CA 94401, USA
    Diabetes Care 28:1231-9. 2005
  16. ncbi A flaw in the use of sulfonylurea screening to diagnose sulfonylurea overdosages
    David C Klonoff
    Dorothy L and James E Frank Diabetes Research Institute, Mills Peninsula Health Services, San Mateo, California 94401, USA
    Diabetes Technol Ther 5:453-4. 2003
  17. pmc The personalized medicine for diabetes meeting summary report
    David C Klonoff
    Mills Peninsula Health Services, San Mateo, California 94401, USA
    J Diabetes Sci Technol 3:677-9. 2009
    ..Additional research is needed to demonstrate the benefits of this approach. The US Air Force is well positioned to conduct research and develop clinical programs in PMFD...
  18. ncbi Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
    David C Klonoff
    Diabetes Research Institute, Mills Peninsula Health Services, San Mateo, CA, USA
    Curr Med Res Opin 24:275-86. 2008
    ..The objective of this study was to evaluate the effects of > or = 3 years exenatide therapy on glycemic control, body weight, cardiometabolic markers, and safety...